Molecular Diagnostics

Genetic Testing for Hypercholesterolemia Improves Diagnosis
Familial Hypercholesterolemia (FH) is caused by a genetic defect that hinders the body's ability to remove low-density lipoprotein (LDL) cholesterol from the blood. High LDL levels in the blood are more likely to result in narrowing of the arteries, which puts patients at substantially higher lifetime risk for heart disease and stroke at an early age. More...16 Aug 2018
Epigenetic Diagnostic Tool Detects Diseases in Newborns
Newborns are routinely screened for inheritable diseases by analyzing dried blood spots (DBS) from blood taken from a heel-prick. Among the more than 300 known primary immune deficiencies (PIDs), only Severe Combined Immunodeficiencies (SCID) are detected at birth with the current technology used to analyze the DBS. More...13 Aug 2018

Urine Test Accurately Detects Bladder Cancer Recurrence
Urinary tests have been studied for the detection of bladder tumors; however, most of these tests have not been implemented in clinical practice because of cost issues, practical aspects, or insufficient sensitivity or specificity as compared to the gold standard. More...10 Aug 2018

FDA Clears Diagnostic Assay for Group B Strep
Group B Streptococcus (GBS) is a Gram-positive bacterium found in 10% to 35% of healthy adults and is a commonly found bacterium within the human body. A person who carries GBS and does not present symptoms of GBS disease is said to be “colonized” with GBS. More...10 Aug 2018

Infections Defined in Urothelial Bladder Tumors
Bladder cancer is estimated to be the 9th most common cancer worldwide and over 90% of bladder tumors are classed as urothelial bladder carcinomas (UBCs), with 75% to 80% presenting at non-muscle-invasive (NMIBC) stages and the remainder presenting at muscle-invasive (MIBC) and metastatic stages. More...09 Aug 2018
In Other News
Fracture Risk Predicted with New Genetic Screen
Susceptible Genes Identified for Childhood Kidney Disease
Mutations Identified As Cause for Rare Bone Marrow Disorder
New Troponin Assays Receive US Marketing Clearance
MicroRNA Panel Delivers Thyroid Cancer Diagnosis
Genetic Alterations Correlated to Aggressive Prostate Cancer
DNA Methylation Linked to Depression in Middle-Aged and Elderly
New Target Protein for Colon Cancer Identified
Neuro Disorders Involving Epilepsy Include Distinct De Novo Variants
Sequencing Produces Better Diagnostics for Pediatric Genetic Disease
Biomarker Detects Active Melanoma and Predicts Survival
Acute Myeloid Leukemia Risk Predicted in Healthy Individuals
Biosensor Chip Detects SNPs with Higher Sensitivity
Cancer Genetics Highlight Mutations Linked to Drug Response
Integrated Analyses Offer Molecular Insights to Tumor Subtypes
Biomarker Discovered for Hypervirulent Pathogen
MicroRNA Pair Serves as Biomarkers for Rapid Sepsis Diagnosis
Optimization of Analytical Procedures Reduces Variability of Results
Genetic Connections Uncovered Between Psychiatric Disorders
Female Bladder Bacteria Reveal Urogenital Microbiota
Lipid Species Offer Insights into Metabolic Health
New Genre of Small-Cell Lung Cancer Discovered
Simple Test Could Reduce Treatment of Bladder Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








